Caring for Dementia Caregivers in Ethnic Immigrant Communities

April 28, 2026 updated by: Yuri Jang, University of Southern California

Many caregivers of people with Alzheimer's disease or other dementias-especially those in immigrant communities who don't speak English well-don't get access to helpful, proven support programs. This is especially true for Korean American caregivers.

To address this, the investigative team adapted an existing caregiver support program (called the Savvy Caregiver Program) to better fit Korean culture and language. This new version, called K-Savvy, is a 6-week online program taught in Korean. In an earlier small study, K-Savvy worked well: caregivers found it helpful, were willing to use it, and showed fewer symptoms of depression.

Now, the investigative team wants to study it more carefully to see how well it really works and why.

The study has two main goals:

Goal 1:

The investigative team will measure whether K-Savvy improves caregivers' well-being-specifically whether it reduces stress and depression and helps them feel more positive about caregiving. The investigative team will also look at why it works, focusing on whether it changes how caregivers think about their situation (for example, feeling less overwhelmed and more confident).

Goal 2:

The investigative team will talk directly with caregivers and program instructors to understand their experiences with K-Savvy. This will help the investigative team learn what worked well, what didn't, and why.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Yuri Jang, PhD
  • Phone Number: 213-821-6441
  • Email: yurij@usc.edu

Study Contact Backup

Study Locations

    • California
      • Los Angeles, California, United States, 90089
        • University of Southern California
        • Contact:
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Self-identified Korean American adults aged 18 or older Provide care for a family member with dementia as a primary caregiver Primary caregiver defined as providing a minimum of 10 hours per week of in-home caregiving to a family member Speak English less than "very well" Able to attend virtual classes using an electronic device with Internet access

Exclusion Criteria:

Individuals with severe depression (Patient Health Questionnaire [PHQ-9] score ≥ 20), as K-Savvy is not a mental health treatment program

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: K-Savvy
immediate enrollment in K-Savvy, 6-week online psychoeducation program
Funded by the NIA (R21AG071790, PI: Jang), our team successfully completed linguistic and cultural adaptations of the Savvy Caregiver Program (SCP) for Korean American dementia caregivers with limited English Proficiency. The Korean version of the SCP (K-Savvy) has shown high feasibility, acceptability, and initial efficacy.
Active Comparator: Healthy Living
enrollment in a 6-week online health education program and subsequent enrollment in K-Savvy
Funded by the NIA (R21AG071790, PI: Jang), our team successfully completed linguistic and cultural adaptations of the Savvy Caregiver Program (SCP) for Korean American dementia caregivers with limited English Proficiency. The Korean version of the SCP (K-Savvy) has shown high feasibility, acceptability, and initial efficacy.
6-week online health education for Korean Americans with limited English proficiency
Other: waitlist control
K-Savvy enrollment after a waiting period
Funded by the NIA (R21AG071790, PI: Jang), our team successfully completed linguistic and cultural adaptations of the Savvy Caregiver Program (SCP) for Korean American dementia caregivers with limited English Proficiency. The Korean version of the SCP (K-Savvy) has shown high feasibility, acceptability, and initial efficacy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
depressive symptoms
Time Frame: from enrollment to 6-month follow-up
symptoms of depression assessed with Patient Health Questionnaire-9, range from 0 to 27 (higher scores indicating greater depressive symptoms)
from enrollment to 6-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
caregiver burden
Time Frame: from enrollment to 6-month follow-up
the level of stress and burden measures with the Zarit's Caregiver Burden Scale, range from 0 to 48 (higher scores indicating greater sense of burden)
from enrollment to 6-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2026

Primary Completion (Estimated)

December 30, 2030

Study Completion (Estimated)

December 30, 2030

Study Registration Dates

First Submitted

April 17, 2026

First Submitted That Met QC Criteria

April 17, 2026

First Posted (Actual)

April 24, 2026

Study Record Updates

Last Update Posted (Actual)

April 30, 2026

Last Update Submitted That Met QC Criteria

April 28, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • R01AG090561 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Study results will be disseminated to the scientific community. De-identified individual participant data (IPD) collected in this study will be made available to qualified researchers upon reasonable request. The shared dataset will include variables necessary to replicate study findings, along with relevant documentation (e.g., data dictionaries and study protocols). Data sharing will be conducted in compliance with human subjects protection regulations and the University of Southern California Institutional Review Board, and in accordance with National Institutes of Health data sharing policies. Access may require a data use agreement to ensure appropriate use and protection of participant confidentiality.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress (Psychology)

Clinical Trials on K-Savvy

Subscribe